Antibiotic tested as new hope for Tough-to-Treat depression
NCT ID NCT03947827
Summary
This study tested whether adding the antibiotic minocycline to standard antidepressant medication helps people with treatment-resistant depression. In this 12-week trial, 76 adults who hadn't responded well to their current antidepressants were randomly assigned to receive either minocycline or a placebo pill in addition to their usual treatment. The goal was to see if minocycline, which may reduce brain inflammation, could safely improve depression symptoms more than a placebo.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TREATMENT RESISTANT DEPRESSION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Centre for Addiction and Mental Health
Toronto, Ontario, M6J 1H4, Canada
Conditions
Explore the condition pages connected to this study.